These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 2225876

  • 1. Acute effect of urapidil on peripheral serotonin metabolism.
    Sebeková K, Fedelesová V, Blazícek P, Dzúrik R.
    Cor Vasa; 1990; 32(4):274-81. PubMed ID: 2225876
    [Abstract] [Full Text] [Related]

  • 2. Effects of urapidil on 5-hydroxytryptamine induced platelet aggregation and on 14C-5-hydroxytryptamine uptake in platelets.
    Storck J, Ochs JG, Kirsten R.
    Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):303-8. PubMed ID: 2387654
    [Abstract] [Full Text] [Related]

  • 3. Platelet deactivation by 5HT2-receptor blockade parallels the antihypertensive response to ketanserin.
    Amstein R, Fetkovska N, Pletscher A, Bühler FR.
    J Hypertens; 1989 Apr; 7(4):255-60. PubMed ID: 2723427
    [Abstract] [Full Text] [Related]

  • 4. Serotonin metabolism and platelet aggregation under antihypertensive treatment with nitrendipine.
    Sebeková K, Raucinová M, Sedláková K, Dzúrik R.
    J Cardiovasc Pharmacol; 1988 Apr; 12 Suppl 4():S161-3. PubMed ID: 2468865
    [Abstract] [Full Text] [Related]

  • 5. Anti-hypertensive treatment with magnesium-aspartate-dichloride and its influence on peripheral serotonin metabolism in man: a subacute study.
    Sebeková K, Revúsová V, Polakovicová D, Drahosová J, Zverková D, Dzúrik R.
    Cor Vasa; 1992 Apr; 34(5-6):390-401. PubMed ID: 1285056
    [Abstract] [Full Text] [Related]

  • 6. Age, platelet serotonin kinetics and 5HT2-receptor blockade in essential hypertension.
    Amstein R, Fetkovska N, Bühler FR.
    J Hum Hypertens; 1990 Aug; 4(4):441-4. PubMed ID: 2258891
    [Abstract] [Full Text] [Related]

  • 7. [The effect of acute administration of ketanserin on the peripheral metabolism of serotonin and hemodynamic indicators in hypertensive patients].
    Sebeková K, Raucinová M, Jurecková K.
    Bratisl Lek Listy; 1990 Nov; 91(11):829-32. PubMed ID: 2265368
    [Abstract] [Full Text] [Related]

  • 8. Urapidil inhibits 5-hydroxytryptamine induced platelet aggregation and 14C-5-hydroxytryptamine uptake in platelets.
    Storck J, Kirsten R.
    Curr Med Res Opin; 1990 Nov; 12(2):86-92. PubMed ID: 2390867
    [Abstract] [Full Text] [Related]

  • 9. 5HT-kinetics and sensitivity of human blood platelets: variations with age, gender and platelet number.
    Fetkovska N, Amstein R, Ferracin F, Regenass M, Bühler FR, Pletscher A.
    Thromb Haemost; 1988 Dec 22; 60(3):486-90. PubMed ID: 2467403
    [Abstract] [Full Text] [Related]

  • 10. Serotonin and platelet activation during treatment with isradipine.
    Fetkovska N, Sebekova K, Fedelesova V, Dzurik R.
    J Cardiovasc Pharmacol; 1991 Dec 22; 18 Suppl 3():S31-3. PubMed ID: 1720482
    [Abstract] [Full Text] [Related]

  • 11. Carmoxirole inhibits platelet aggregation in vitro and ex vivo.
    Kirsten R, Breidert M, Sparwasser K, Ochs JG, Hesse K, Nelson K.
    Int J Clin Pharmacol Ther; 1995 Feb 22; 33(2):76-80. PubMed ID: 7757314
    [Abstract] [Full Text] [Related]

  • 12. Age and 5HT 2-receptor blockade with ketanserin in essential hypertension.
    Bühler FR, Amstein R.
    Rev Port Cardiol; 1989 Sep 22; 8(9):621-4. PubMed ID: 2698721
    [Abstract] [Full Text] [Related]

  • 13. [Inhibition of thrombocyte activity in atherogenesis and thrombogenesis using isradipine and other calcium antagonists].
    Fet'kovská N, Ulicná L, Jakubovská Z.
    Vnitr Lek; 1993 Apr 22; 39(4):326-33. PubMed ID: 8351859
    [Abstract] [Full Text] [Related]

  • 14. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
    Jagroop IA, Matsagas MI, Geroulakos G, Mikhailidis DP.
    Platelets; 2004 Mar 22; 15(2):117-25. PubMed ID: 15154604
    [Abstract] [Full Text] [Related]

  • 15. Hemorheology of arterial hypertension: influence of urapidil.
    Delamaire M, Bernard MD, Boisseau MR.
    Blood Press Suppl; 1995 Mar 22; 3():58-61. PubMed ID: 8535543
    [Abstract] [Full Text] [Related]

  • 16. Trapidil decreases the aggregation of platelets from heart transplant recipients ex vivo.
    Jovin IS, Taborski U, Szalay Z, Friedel A, Segieth I, Jovin A, Heidinger K, Schreiner K, Frass O, Klövekorn WP, Müller-Berghaus G.
    Transplant Proc; 2006 Jun 22; 38(5):1523-5. PubMed ID: 16797349
    [Abstract] [Full Text] [Related]

  • 17. In vivo effect of losartan on platelet aggregation in patients with hypertension.
    Akdemir R, Ozhan H, Yazici M, Gunduz H, Duran S, Gurel C, Ozdas S, Uyan C, Basar I, Ulutin T.
    Heart Vessels; 2004 Jul 22; 19(4):167-71. PubMed ID: 15278389
    [Abstract] [Full Text] [Related]

  • 18. The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation.
    Jagroop IA, Mikhailidis DP.
    Clin Appl Thromb Hemost; 2008 Jul 22; 14(3):295-302. PubMed ID: 18445610
    [Abstract] [Full Text] [Related]

  • 19. Serotonin and 5-hydroxyindole-acetic acid.
    Sebekova K, Spustova V, Opatrny K, Dzurik R.
    Bratisl Lek Listy; 2001 Jul 22; 102(8):351-6. PubMed ID: 11763663
    [Abstract] [Full Text] [Related]

  • 20. Modulation of serotonergic and adrenergic systems by long-term antihypertensive treatment with enalapril.
    Sebeková K, Jurecková K, Raucinová M, Balazovjech I, Dzúrik R.
    Cor Vasa; 1991 Jul 22; 33(3):206-17. PubMed ID: 1717198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.